Bayesian calibration of a natural history model with application to a population model for colorectal cancer

Medical Decision Making

Volumn 31, Issue 4, 2011, Pages 625-641

  Whyte, Sophie ^a   Walsh, Cathal ^b,c   Chilcott, Jim ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

Bayesian; calibration; colorectal cancer; natural history

Indexed keywords

AGED; ARTICLE; BAYES THEOREM; CALIBRATION; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; HUMAN; PREVALENCE; PROBABILITY;

AGED; BAYES THEOREM; CALIBRATION; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; HUMANS; MARKOV CHAINS; PREVALENCE; PROBABILITY;

EID: 79960481291     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X10384738     Document Type: Review

References (39)

1. Tappenden P, Eggington S, Nixon R, Karnon J, Sakai H, Chilcott J Sheffield, UK: University of Sheffield ; 2004 :
2. Karnon J, Goyder E, Tappenden P, et al. A review and critique of modelling in prioritising and designing screening programmes. Health Technol Assess. 2007 ; 11 (52). iii 1 - xi
3. Kim JJ, Kuntz KM, Stout NK, et al. Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol. 2007 ; 166: 137-50 (Pubitemid 47227293)
4. Blower SM, Koelle K, Kirschner DE, Mills J. Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety. Proc Natl Acad Sci U S A. 2001 ; 98: 3618-23 (Pubitemid 32220894)
5. Harper PR, Jones SK. Mathematical models for the early detection and treatment of colorectal cancer. Health Care Manag Sci. 2005 ; 8: 101-9 (Pubitemid 40685114)
6. The Cancer Incidence and Surveillance Network (CISNET) website. www.cisnet.cancer.gov/colorectal/profiles.html
7. Loeve F, Boer R, van Oortmarssen GJ, van Ballegooijen Habbema JD. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res. 1999 ; 32: 13-33 (Pubitemid 29102594)
8. Rutter M, Miglioretti DL, Savarino JE. Bayesian calibration of microsimulation models. J Am Stat Assoc. 2009 ; 104: 1338-50
9. Higdon D, Kennedy M, Cavendish J, Cafeo J, Ryne RD. Combining field data and computer simulations for calibration and prediction. SIAM J Sci Comput. 2004 ; 26: 448-66
10. Goldstein M, Rougier J. Bayes linear calibrated prediction for complex systems. J Am Stat Assoc. 2006 ; 101 (475). 1132-43 (Pubitemid 44422613)
11. Spiegelhalter DJ. Incorporating Bayesian ideas into health-care evaluation. Stat Sci. 2004 ; 19: 156-74 (Pubitemid 39056884)
12. National Institute for Health and Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal. 2008. Available from: http://www.nice.org. uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf.
13. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner DA, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. Br Med J. 2003 ; 326: 1235
14. Welton NJ, Ades AE. Estimation of Markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration. Med Decis Making. 2005 ; 25: 633-45 (Pubitemid 41667132)
15. Tappenden P, Chilcott J, Eggington S, Patnick J, Sakai H, Karnon J. Option appraisal of population-based colorectal cancer screening programmes in England. Gut. 2007 ; 56: 677-84 (Pubitemid 46662935)
16. NHS Bowel Cancer Screening Programme. 2009. Available from: www.cancerscreening.nhs.uk/bowel/
17. Sharp L, Céilleachair A, Comber H, et al Options for a Population-Based Colorectal Cancer Screening Programme in Ireland: A Health Technology Assessment. Cork, Ireland: Health Information & Quality Authority ; 2009 :
18. Nickerson C Data from First Round of Bowel Cancer Screening in England. Sheffield, UK: NHS Cancer Screening Programmes ; 2009 :
19. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut. 2002 ; (51 Suppl 5). V6 - V9
20. Cotton S, Sharp L, Little J. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. Crit Rev Oncog. 1996 ; 7: 293-342
21. Roberts GO, Gelman A, Gilks WR. Weak convergence and optimal scaling of random walk Metropolis algorithms. Ann Appl Probab. 1997 ; 7: 110-20
22. Plummer M, Best N, Cowles K, Vines K. CODA: Output analysis and diagnostics for MCMC. R News. 2006 ; 6: 7-11
23. Incidence Data and Relative Survival Rates Calculated from the National Cancer Data Repository. Leeds, UK: Northern & Yorkshire Cancer Registry & Information Service and the National Cancer Intelligence Network ; 2009 :
24. Cancer Registry Population Denominators. Newport, South Wales: Office for National Statistics ; 2009 :
25. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003 ; 18 (suppl 2). 1-5 (Pubitemid 37174709)
26. Pendergrass CJ, Edelstein DL, Hylind LM, et al. Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol. 2008 ; 6: 1011-5
27. Eide TJ, Stalsberg H. Polyps of the large intestine in northern Norway. Cancer. 1978 ; 42: 2839-48 (Pubitemid 9107564)
28. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous lesions of the large bowel: an autopsy survey. Cancer. 1979 ; 43: 1847-57 (Pubitemid 9203736)
29. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982 ; 23: 835-42 (Pubitemid 12018511)
30. Blatt LJ. Polyps of the colon and rectum: incidence and distribution. Dis Colon Rectum. 1961 ; 4: 277-82
31. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 1982 ; 49: 819-25 (Pubitemid 12165443)
32. Arminski TC, McLean DW. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Dis Colon Rectum. 1964 ; 7: 249-61
33. Office of National Statistics. Interim Life Tables 2005-07. 2009. Available from: www.statistics.gov.uk/StatBase/Product.asp?vlnk=14459
34. Burch JA, Soares-Weiser K, St John DJ, et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen. 2007 ; 14: 132-7 (Pubitemid 47511122)
35. Weller D, Coleman D, Robertson R, et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer. 2007 ; 97: 1601-5 (Pubitemid 350249359)
36. TappendenPEggingtonSNixonRChilcottJSakaiHKarnonJ. Colorectal cancer screening options appraisal. Report to the English Bowel Cancer Screening Working Group. 2004. Available from: http://www.cancerscreening.nhs.uk/bowel/ scharr.pdf
37. Chib S, Greenberg E. Understanding the Metropolis-Hastings algorithm. Am Stat. 1995 ; 49: 327-35 (Pubitemid 126008969)
38. Cowles MK, Carlin BP. Markov chain Monte Carlo convergence diagnostics: a comparative review. J Am Stat Assoc. 1996 ; 91: 883-904
39. Brooks SP, Roberts GO. Convergence assessment techniques for Markov chain Monte Carlo. Stat Comput. 1998 ; 8: 319-35